No Data
No Data
Heron Therapeutics Down Over 19%, On Pace for Largest Percent Decrease Since May 2023 -- Data Talk
Heron Therapeutics Inc.(HRTX) is currently at $2.79, down $0.68 or 19.62% --Would be lowest close since May 10, 2024, when it closed at $2.77 --On pace for largest percent decrease since May 12, 202
Express News | Heron Therapeutics Shares Are Trading Lower. The FDA Acknowledged the Receipt of the Company's Prior Approval Supplement Application for ZYNRELEF
Heron Therapeutics' ZYNRELEF Review Date Set by FDA
Express News | Heron Therapeutics Inc - U.S. Food and Drug Administration ("FDA") Assigned a Prescription Drug User Fee Act ("Pdufa") Goal Date of September 23, 2024
Express News | Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle ("Van")
Despite Shrinking by US$52m in the Past Week, Heron Therapeutics (NASDAQ:HRTX) Shareholders Are Still up 181% Over 1 Year
When you buy shares in a company, there is always a risk that the price drops to zero. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Heron The